No Data
BioLife Solutions Is Maintained at Buy by TD Cowen
BioLife Solutions Is Maintained at Buy by TD
BioLife Solutions Price Target Raised to $26.00/Share From $20.00 by TD Cowen
BioLife Solutions Price Target Raised to $26.00/Share From $20.00 by TD
BioLife Solns Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/17/2024 15.3% TD Cowen $20 → $26 Maintains Buy 05/13/2024 10.86% Benchmark → $25 Upgrades Hold → Buy 04
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $26
TD Cowen analyst Steven Mah maintains $BioLife Solutions(BLFS.US)$ with a buy rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 26.9% and a
Express News | BioLife Solutions Inc : TD Cowen Raises Target Price to $26 From $20
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $26
TD Cowen analyst Steven Mah maintains $BioLife Solutions(BLFS.US)$ with a buy rating, and adjusts the target price from $20 to $26.According to TipRanks data, the analyst has a success rate of 26.9%